Aldosterone and prednisolone control of cochlear function in MRL/MpJ-Faslpr autoimmune mice

Dennis Trune, J. Beth Kempton

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Recently this laboratory showed aldosterone, a mineralocorticoid that only enhances sodium transport, was as effective as the glucocorticoid prednisolone in restoring cochlear function in autoimmune mice. To further test this relationship between sodium transport and autoimmune hearing loss, dosage comparisons were made of prednisolone and aldosterone control of the auditory dysfunction in autoimmune MRL/MpJ-Faslpr mice. Mice were tested at 2 months of age to establish baseline auditory brainstem response (ABR) thresholds, hematocrit, serum immune complexes, and anti-nuclear antibodies. Mice were then given different doses of prednisolone or aldosterone in their drinking water for 2 months. After the treatment period, most untreated water controls showed elevation of ABR thresholds due to the ongoing autoimmune disease. However, the steroid groups had significantly more mice with improved or unchanged thresholds. Both steroids improved stria vascularis morphology, although aldosterone appeared to be more effective. The immune suppressive prednisolone caused a dose-related improvement in levels of serum immune complexes and hematocrit, hallmarks of systemic autoimmune disease. Aldosterone, which has no immune suppressive function, did not alter systemic disease. The comparable efficacy of prednisolone and aldosterone in restoring auditory function suggests steroid reversal of autoimmune hearing loss in mice is due to increasing stria vascularis sodium transport and not suppression of systemic autoimmune reactions.

Original languageEnglish (US)
Pages (from-to)9-20
Number of pages12
JournalHearing Research
Volume155
Issue number1-2
DOIs
StatePublished - 2001

Fingerprint

Cochlea
Prednisolone
Aldosterone
Stria Vascularis
Brain Stem Auditory Evoked Potentials
Sodium
Steroids
Antigen-Antibody Complex
Hematocrit
Hearing Loss
Autoimmune Diseases
Mineralocorticoids
Serum
Drinking Water
Glucocorticoids
Anti-Idiotypic Antibodies
Water

Keywords

  • Aldosterone
  • Autoimmune hearing loss
  • MRL/MpJ-Fas autoimmune mouse
  • Prednisolone
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Sensory Systems

Cite this

Aldosterone and prednisolone control of cochlear function in MRL/MpJ-Faslpr autoimmune mice. / Trune, Dennis; Kempton, J. Beth.

In: Hearing Research, Vol. 155, No. 1-2, 2001, p. 9-20.

Research output: Contribution to journalArticle

@article{69601f7ad5f84fde8f772745ec86f3ed,
title = "Aldosterone and prednisolone control of cochlear function in MRL/MpJ-Faslpr autoimmune mice",
abstract = "Recently this laboratory showed aldosterone, a mineralocorticoid that only enhances sodium transport, was as effective as the glucocorticoid prednisolone in restoring cochlear function in autoimmune mice. To further test this relationship between sodium transport and autoimmune hearing loss, dosage comparisons were made of prednisolone and aldosterone control of the auditory dysfunction in autoimmune MRL/MpJ-Faslpr mice. Mice were tested at 2 months of age to establish baseline auditory brainstem response (ABR) thresholds, hematocrit, serum immune complexes, and anti-nuclear antibodies. Mice were then given different doses of prednisolone or aldosterone in their drinking water for 2 months. After the treatment period, most untreated water controls showed elevation of ABR thresholds due to the ongoing autoimmune disease. However, the steroid groups had significantly more mice with improved or unchanged thresholds. Both steroids improved stria vascularis morphology, although aldosterone appeared to be more effective. The immune suppressive prednisolone caused a dose-related improvement in levels of serum immune complexes and hematocrit, hallmarks of systemic autoimmune disease. Aldosterone, which has no immune suppressive function, did not alter systemic disease. The comparable efficacy of prednisolone and aldosterone in restoring auditory function suggests steroid reversal of autoimmune hearing loss in mice is due to increasing stria vascularis sodium transport and not suppression of systemic autoimmune reactions.",
keywords = "Aldosterone, Autoimmune hearing loss, MRL/MpJ-Fas autoimmune mouse, Prednisolone, Systemic lupus erythematosus",
author = "Dennis Trune and Kempton, {J. Beth}",
year = "2001",
doi = "10.1016/S0378-5955(01)00240-4",
language = "English (US)",
volume = "155",
pages = "9--20",
journal = "Hearing Research",
issn = "0378-5955",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Aldosterone and prednisolone control of cochlear function in MRL/MpJ-Faslpr autoimmune mice

AU - Trune, Dennis

AU - Kempton, J. Beth

PY - 2001

Y1 - 2001

N2 - Recently this laboratory showed aldosterone, a mineralocorticoid that only enhances sodium transport, was as effective as the glucocorticoid prednisolone in restoring cochlear function in autoimmune mice. To further test this relationship between sodium transport and autoimmune hearing loss, dosage comparisons were made of prednisolone and aldosterone control of the auditory dysfunction in autoimmune MRL/MpJ-Faslpr mice. Mice were tested at 2 months of age to establish baseline auditory brainstem response (ABR) thresholds, hematocrit, serum immune complexes, and anti-nuclear antibodies. Mice were then given different doses of prednisolone or aldosterone in their drinking water for 2 months. After the treatment period, most untreated water controls showed elevation of ABR thresholds due to the ongoing autoimmune disease. However, the steroid groups had significantly more mice with improved or unchanged thresholds. Both steroids improved stria vascularis morphology, although aldosterone appeared to be more effective. The immune suppressive prednisolone caused a dose-related improvement in levels of serum immune complexes and hematocrit, hallmarks of systemic autoimmune disease. Aldosterone, which has no immune suppressive function, did not alter systemic disease. The comparable efficacy of prednisolone and aldosterone in restoring auditory function suggests steroid reversal of autoimmune hearing loss in mice is due to increasing stria vascularis sodium transport and not suppression of systemic autoimmune reactions.

AB - Recently this laboratory showed aldosterone, a mineralocorticoid that only enhances sodium transport, was as effective as the glucocorticoid prednisolone in restoring cochlear function in autoimmune mice. To further test this relationship between sodium transport and autoimmune hearing loss, dosage comparisons were made of prednisolone and aldosterone control of the auditory dysfunction in autoimmune MRL/MpJ-Faslpr mice. Mice were tested at 2 months of age to establish baseline auditory brainstem response (ABR) thresholds, hematocrit, serum immune complexes, and anti-nuclear antibodies. Mice were then given different doses of prednisolone or aldosterone in their drinking water for 2 months. After the treatment period, most untreated water controls showed elevation of ABR thresholds due to the ongoing autoimmune disease. However, the steroid groups had significantly more mice with improved or unchanged thresholds. Both steroids improved stria vascularis morphology, although aldosterone appeared to be more effective. The immune suppressive prednisolone caused a dose-related improvement in levels of serum immune complexes and hematocrit, hallmarks of systemic autoimmune disease. Aldosterone, which has no immune suppressive function, did not alter systemic disease. The comparable efficacy of prednisolone and aldosterone in restoring auditory function suggests steroid reversal of autoimmune hearing loss in mice is due to increasing stria vascularis sodium transport and not suppression of systemic autoimmune reactions.

KW - Aldosterone

KW - Autoimmune hearing loss

KW - MRL/MpJ-Fas autoimmune mouse

KW - Prednisolone

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=0035032762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035032762&partnerID=8YFLogxK

U2 - 10.1016/S0378-5955(01)00240-4

DO - 10.1016/S0378-5955(01)00240-4

M3 - Article

C2 - 11335072

AN - SCOPUS:0035032762

VL - 155

SP - 9

EP - 20

JO - Hearing Research

JF - Hearing Research

SN - 0378-5955

IS - 1-2

ER -